Contact
Home • Insights

Latest thinking.

Explore our latest insights and perspectives in these life science resources, news articles, and events.

Scroll

Reflections of an Evolving Medical Affairs Skillset:...

MASS West 2024 showcased key themes in health equity, AI, and Real-World Evidence, helping Medical Affairs leaders tackle evolving challenges.

Read more

Introducing ClarityNav: A new way to analyze medical...

ClarityNav, harnessed by our consultants, is redefining how medical insights are gathered, analyzed, and applied.

Read more

From action to impact to patient value: Highlights f...

Over 400 Medical Affairs professionals gathered at the MAPS 2024 EMEA Annual Meeting. Learn more about some key takeaways we had from our attendance.

Read more

Highlights from the Fierce Medical Affairs Strategic...

The Fierce Medical Affairs Strategic Summit (MASS) East conference convened May 6-8, 2024 in Jersey City, NJ, attracting Medical leaders across...

Read more

Putnam welcomes new Partner to the Medical & Sci...

Putnam is pleased to welcome a new Partner to the team, Rudiger Papsch, based in the UK, who will be a central expert in our Medical & Scientific ....

Read more

Highlights from the CMO Summit 2024 (Boston, MA)

Learn about the key highlights from the 12th annual CMO Summit in Boston, MA, convening Chief Medical Officers (CMOs) and Medical leaders across...

Read more

Leading world-class Medical Affairs into the future:...

We recently reconvened our Medical Affairs Leadership Council, discussing top of mind topics with leaders.

Read more

Learnings from MAPS Americas 2024

Putnam experts share key learnings coming out of MAPS Americas 2024

Read more

CNS indication/ Endpoint prioritization

A biopharma client with an early clinical stage compound, showing efficacy across multiple neuropsychiatric conditions, wished to prioritize...

Read more

Medical Affairs omnichannel platform

A large biopharma client objective aimed to optimize its omnichannel (OC) approach for HCP and patient Medical Education...

Read more

Rare respiratory claims data analysis

A top biopharma client wanted to understand diagnosis and treatment patterns for a rare respiratory disease only recently associated as a sequela....

Read more

Rare disease research consortium guidance on AI diag...

A rare disease research consortium sought to identify barriers to adoption of AI-enabled, point-of-care diagnostic decision support tools..

Read more

Get in touch.

Looking to get in touch with an expert or team member?

Tell us how we can help.

Get in touch